Literature DB >> 18668669

Donor safety and remnant liver volume in living donor liver transplantation.

C Burcin Taner1, Murat Dayangac, Baris Akin, Deniz Balci, Suleyman Uraz, Cihan Duran, Refik Killi, Omer Ayanoglu, Yildiray Yuzer, Yaman Tokat.   

Abstract

Living donor liver transplantation is now a common practice in countries in which the availability of cadaveric organs is limited. The preoperative preparation, intraoperative surgical technique, and postoperative care of donors and recipients have evolved in recent years. We retrospectively compared 67 donors with a remnant liver volume equal to or more than 30% (group 1) with 14 donors who had less than 30% remnant liver volume (group 2) for donor outcomes. All the complications in donors were systematically classified. Donors with less than 30% remnant liver volume showed significantly higher peak aspartate aminotransferase, alanine aminotransferase, international normalized ratio, and bilirubin levels. There were 6 complications in group 1 and 4 complications in group 2. The difference between the 2 groups in terms of donor complications did reach statistical significance (P = 0.043); donors with a remnant liver volume < 30% had a 4 times greater relative risk of morbidity. In conclusion, the use of donors with less than 30% remnant liver volume is highly debatable as donor safety should be of utmost importance in living donor liver transplantation.

Entities:  

Mesh:

Year:  2008        PMID: 18668669     DOI: 10.1002/lt.21562

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  14 in total

1.  Ratio of remnant to total liver volume or remnant to body weight: which one is more predictive on donor outcomes?

Authors:  Onur Yaprak; Necdet Guler; Gulum Altaca; Murat Dayangac; Tolga Demirbas; Murat Akyildiz; Levent Ulusoy; Yaman Tokat; Yildiray Yuzer
Journal:  HPB (Oxford)       Date:  2012-07       Impact factor: 3.647

2.  Transplantation: Minimizing the risks for living donors of right lobe liver grafts.

Authors:  Hiroto Egawa
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-05       Impact factor: 46.802

3.  Remnant left liver size and recovery of living right liver donors.

Authors:  Yuen Ki Fong; See Ching Chan; Tan To Cheung; Wing Chiu Dai; Kenneth S H Chok; Albert C Y Chan; William W Sharr; Chung Mau Lo
Journal:  Hepatol Int       Date:  2012-11-14       Impact factor: 6.047

4.  Pros and cons of living donor liver transplant.

Authors:  Robert S Brown
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-09

5.  Donor outcome in live-related liver transplantation.

Authors:  P P Rao; D Routh; C S Naidu; Sanjay Sharma; A K Sharma; V Trehan; Amit Gaur
Journal:  Med J Armed Forces India       Date:  2013-12-16

Review 6.  The evolution of anterior sector venous drainage in right lobe living donor liver transplantation: does one technique fit all?

Authors:  Murat Dayangac; Yaman Tokat
Journal:  Hepatobiliary Surg Nutr       Date:  2016-04       Impact factor: 7.293

7.  Computed tomography liver volumetry using 3-dimensional image data in living donor liver transplantation: effects of the slice thickness on the volume calculation.

Authors:  Masatoshi Hori; Kenji Suzuki; Mark L Epstein; Richard L Baron
Journal:  Liver Transpl       Date:  2011-12       Impact factor: 5.799

8.  Outcomes in partial liver transplantation: deceased donor split-liver vs. live donor liver transplantation.

Authors:  Reza F Saidi; Nicolas Jabbour; Youfu Li; Shimul A Shah; Adel Bozorgzadeh
Journal:  HPB (Oxford)       Date:  2011-09-14       Impact factor: 3.647

9.  Is left lobe adult-to-adult living donor liver transplantation ready for widespread use? The US experience (1998-2010).

Authors:  Reza F Saidi; Nicolas Jabbour; YouFu Li; Shimul A Shah; Adel Bozorgzadeh
Journal:  HPB (Oxford)       Date:  2012-05-11       Impact factor: 3.647

10.  Donor safety and remnant liver volume in living donor liver transplantation.

Authors:  Zheng-Rong Shi; Lu-Nan Yan; Cheng-You Du
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.